Synthesis and Preclinical Evaluation of an 18F-Labeled Synaptic Vesicle Glycoprotein 2A PET Imaging Probe: [18F]SynVesT-2

被引:37
作者
Cai, Zhengxin [1 ]
Li, Songye [1 ]
Zhang, Wenjie [1 ,2 ]
Pracitto, Richard [1 ]
Wu, Xiaoai [1 ,2 ]
Baum, Evan [1 ]
Finnema, Sjoerd J. [1 ]
Holden, Daniel [1 ]
Toyonaga, Takuya [1 ]
Lin, Shu-fei [1 ]
Lindemann, Marcel [1 ]
Shirali, Anupama [1 ]
Labaree, David C. [1 ]
Ropchan, Jim [1 ]
Nabulsi, Nabeel [1 ]
Carson, Richard E. [1 ]
Huang, Yiyun [1 ]
机构
[1] Yale Univ, PET Ctr, Dept Radiol & Biomed Imaging, New Haven, CT 06520 USA
[2] Sichuan Univ, West China Hosp, Dept Nucl Med, Lab Clin Nucl Med, Chengdu 610041, Sichuan, Peoples R China
关键词
SV2A; PET; non-human primate; Alzheimer's disease; Parkinson's disease; fluorine-18; MEDIATED RADIOFLUORINATION; BINDING CHARACTERISTICS; PROTEIN; 2A; LATE-STAGE; SV2A; LEVETIRACETAM; TRACER; FLUORINATION; ROUTE; BRAIN;
D O I
10.1021/acschemneuro.9b00618
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Synaptic vesicle glycoprotein 2A (SV2A) is a 12-pass transmembrane glycoprotein ubiquitously expressed in presynaptic vesicles. In vivo imaging of SV2A using PET has potential applications in the diagnosis and prognosis of a variety of neuropsychiatric diseases, e.g., Alzheimer's disease, Parkinson's disease, schizophrenia, multiple sclerosis, autism, epilepsy, stroke, traumatic brain injury, post-traumatic stress disorder, depression, etc. Herein, we report the synthesis and evaluation of a new F-18-labeled SV2A PET imaging probe, [F-18]SynVesT-2, which possesses fast in vivo binding kinetics and high specific binding signals in non-human primate brain.
引用
收藏
页码:592 / 603
页数:23
相关论文
共 55 条
[1]  
Bahri Mohamed Ali, 2017, Alzheimers Dement (N Y), V3, P481, DOI 10.1016/j.trci.2017.08.004
[2]   SV2, A BRAIN SYNAPTIC VESICLE PROTEIN HOMOLOGOUS TO BACTERIAL TRANSPORTERS [J].
BAJJALIEH, SM ;
PETERSON, K ;
SHINGHAL, R ;
SCHELLER, RH .
SCIENCE, 1992, 257 (5074) :1271-1273
[3]   Reduction of Hippocampal Hyperactivity Improves Cognition in Amnestic Mild Cognitive Impairment [J].
Bakker, Arnold ;
Krauss, Gregory L. ;
Albert, Marilyn S. ;
Speck, Caroline L. ;
Jones, Lauren R. ;
Stark, Craig E. ;
Yassa, Michael A. ;
Bassett, Susan S. ;
Shelton, Amy L. ;
Gallagher, Michela .
NEURON, 2012, 74 (03) :467-474
[4]   Pharmacokinetic Characterization of [18F]UCB-H PET Radiopharmaceutical in the Rat Brain [J].
Becker, Guillaume ;
Warnier, Corentin ;
Serrano, Maria Elisa ;
Bahri, Mohamed Ali ;
Mercier, Joel ;
Lemaire, Christian ;
Salmon, Eric ;
Luxen, Andre ;
Plenevaux, Alain .
MOLECULAR PHARMACEUTICS, 2017, 14 (08) :2719-2725
[5]   Biodistribution and Radiation Dosimetry for the Novel SV2A Radiotracer [18F]UCB-H: First-in-Human Study [J].
Bretin, F. ;
Bahri, M. A. ;
Bernard, C. ;
Warnock, G. ;
Aerts, J. ;
Mestdagh, N. ;
Buchanan, T. ;
Otoul, C. ;
Koestler, F. ;
Mievis, F. ;
Giacomelli, F. ;
Degueldre, C. ;
Hustinx, R. ;
Luxen, A. ;
Seret, A. ;
Plenevaux, A. ;
Salmon, E. .
MOLECULAR IMAGING AND BIOLOGY, 2015, 17 (04) :557-564
[6]   Late-stage [18F]fluorination: new solutions to old problems [J].
Brooks, Allen F. ;
Topczewski, Joseph J. ;
Ichiishi, Naoko ;
Sanford, Melanie S. ;
Scott, Peter J. H. .
CHEMICAL SCIENCE, 2014, 5 (12) :4545-4553
[7]   Radiosynthesis of 11C-Levetiracetam: A Potential Marker for PET Imaging of SV2A Expression [J].
Cai, Hancheng ;
Mangner, Thomas J. ;
Muzik, Otto ;
Wang, Ming-Wei ;
Chugani, Diane C. ;
Chugani, Harry T. .
ACS MEDICINAL CHEMISTRY LETTERS, 2014, 5 (10) :1152-1155
[8]  
Cai Z., 2017, J NUCL MED, V58, pS547
[9]   PET imaging of synaptic density: A new tool for investigation of neuropsychiatric diseases [J].
Cai, Zhengxin ;
Li, Songye ;
Matuskey, David ;
Nabulsi, Nabeel ;
Huang, Yiyun .
NEUROSCIENCE LETTERS, 2019, 691 :44-50
[10]   Late-Stage Fluorination: From Fundamentals to Application [J].
Campbell, Michael G. ;
Ritter, Tobias .
ORGANIC PROCESS RESEARCH & DEVELOPMENT, 2014, 18 (04) :474-480